Literature DB >> 8150075

Expression of a bovine vesicular monoamine transporter in COS cells.

B Gasnier1, E Krejci, D Botton, J Massoulié, J P Henry.   

Abstract

Catecholamines are accumulated in vesicles by a proton gradient-dependent transport, which has mostly been studied in bovine chromaffin granules. The full sequence of a cDNA encoding a vesicular transporter from bovine chromaffin cells, bVMAT2, was recently reported. We now present an analysis of bVMAT2, expressed in transfected COS cells. Comparing the binding of a labelled ligand, [3H]TBZOH, and the rate of uptake, we find a much lower molecular turnover number than in chromaffin granules, probably indicating that a majority of expressed transporters are correctly folded and possess the ligand binding site but cannot actively transport monoamines because they are located in compartments which do not possess a proton gradient. The substrate specificity of uptake and its pharmacological sensitivity to various inhibitors closely resemble those previously observed in chromaffin granules. These results suggest that VMAT2 is the major transporter in bovine adrenal glands, and raise the question of the significance of the second related transporter, VMAT1, which is also expressed in this tissue.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8150075     DOI: 10.1016/0014-5793(94)80506-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase enhance dopamine delivery after L-3, 4-dihydroxyphenylalanine administration in Parkinsonian rats.

Authors:  W Y Lee; J W Chang; N L Nemeth; U J Kang
Journal:  J Neurosci       Date:  1999-04-15       Impact factor: 6.167

2.  Cotransfecting norepinephrine transporter and vesicular monoamine transporter 2 genes for increased retention of metaiodobenzylguanidine labeled with iodine 131 in malignant hepatocarcinoma cells.

Authors:  Yanlin Zhao; Xiao Zhong; Xiaohong Ou; Huawei Cai; Xiaoai Wu; Rui Huang
Journal:  Front Med       Date:  2017-03-02       Impact factor: 4.592

3.  Expression of neurotransmitter transporters for structural and biochemical studies.

Authors:  Yael Elbaz; Tsafi Danieli; Baruch I Kanner; Shimon Schuldiner
Journal:  Protein Expr Purif       Date:  2010-06-08       Impact factor: 1.650

Review 4.  Vesicular neurotransmitter transporters. Potential sites for the regulation of synaptic function.

Authors:  H Varoqui; J D Erickson
Journal:  Mol Neurobiol       Date:  1997-10       Impact factor: 5.590

Review 5.  Vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistry.

Authors:  Kandatege Wimalasena
Journal:  Med Res Rev       Date:  2010-02-04       Impact factor: 12.944

6.  Divergent properties and independent regulation of striatal dopamine and GABA co-transmission.

Authors:  Sarah M Zych; Christopher P Ford
Journal:  Cell Rep       Date:  2022-05-17       Impact factor: 9.995

7.  Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter.

Authors:  J D Erickson; M K Schafer; T I Bonner; L E Eiden; E Weihe
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.